{
  "title": "IFRS_2 Disclosure Checklist",
  "version": "1.0",
  "sections": [
    {
      "section": "IFRS_2",
      "title": "Share-based payment",
      "description": "Checklist for presentation and disclosure requirements under IFRS 2.",
      "items": [
        {
          "id": "535.1",
          "section": "IFRS_2",
          "reference": "IFRS 2.44, IFRS 2.45",
          "question": "Has the entity disclosed the vesting requirements for each type of share-based payment arrangement that existed during the period?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "535.2",
          "section": "IFRS_2",
          "reference": "IFRS 2.44, IFRS 2.45",
          "question": "Has the entity disclosed the range of exercise prices for each type of share-based payment arrangement that existed during the period?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "535.3",
          "section": "IFRS_2",
          "reference": "IFRS 2.44, IFRS 2.45",
          "question": "Has the entity disclosed the weighted average remaining contractual life for each type of share-based payment arrangement that existed during the period?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.1",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed the weighted average fair value of share options granted during the period at the measurement date?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.2",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed the option pricing model used to measure the fair value of share options granted during the period?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.3",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed the weighted average share price used as an input to the option pricing model for share options granted during the period?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.4",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed the exercise price used as an input to the option pricing model for share options granted during the period?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.5",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed the number of other equity instruments granted during the period at the measurement date?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.6",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed the weighted average fair value of other equity instruments granted during the period at the measurement date?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.7",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "If fair value of other equity instruments was not measured based on an observable market price, has the entity disclosed how it was determined?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.8",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed whether and how expected dividends were incorporated into the measurement of fair value of other equity instruments granted during the period?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.9",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed whether and how any other features of other equity instruments granted during the period were incorporated into the measurement of fair value?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.10",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed an explanation of any modifications to share-based payment arrangements made during the period?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.11",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed the incremental fair value granted as a result of modifications to share-based payment arrangements during the period?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "536.12",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.47",
          "question": "Has the entity disclosed how the incremental fair value granted as a result of modifications was measured, consistent with the requirements for share options and other equity instruments?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "537.1",
          "section": "IFRS_2",
          "reference": "IFRS 2.46, IFRS 2.48",
          "question": "Has the entity disclosed how the fair value of goods or services received during the period was determined?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "538.1",
          "section": "IFRS_2",
          "reference": "IFRS 2.49",
          "question": "If equity-settled share-based payment transactions involve parties other than employees and the entity cannot reliably estimate the fair value of the goods or services received, has the entity disclosed that fact?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "538.2",
          "section": "IFRS_2",
          "reference": "IFRS 2.49",
          "question": "If equity-settled share-based payment transactions involve parties other than employees and the entity cannot reliably estimate fair value, has the entity disclosed why it rebutted the presumption?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "539.1",
          "section": "IFRS_2",
          "reference": "IFRS 2.50, IFRS 2.51",
          "question": "Has the entity disclosed the total expense recognized for the period relating to share-based payment transactions in which the goods or services received do not qualify for recognition as assets and are recognized immediately as an expense?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "539.2",
          "section": "IFRS_2",
          "reference": "IFRS 2.50, IFRS 2.51",
          "question": "Has the entity separately disclosed the portion of that total expense that arises from equity-settled share-based payment transactions?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "539.3",
          "section": "IFRS_2",
          "reference": "IFRS 2.50, IFRS 2.51",
          "question": "For liabilities arising from share-based payment transactions, has the entity disclosed the total carrying amount at the end of the period?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "539.4",
          "section": "IFRS_2",
          "reference": "IFRS 2.50, IFRS 2.51",
          "question": "For liabilities arising from share-based payment transactions, has the entity disclosed the total intrinsic value at the end of the period of those liabilities for which the counterparty’s right to cash or other assets had vested by period end?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "540.1",
          "section": "IFRS_2",
          "reference": "IFRS 2.52",
          "question": "Has the entity disclosed additional information necessary to satisfy the presentation and disclosure principles in IFRS 2.44, IFRS 2.46, and IFRS 2.50?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        },
        {
          "id": "541.1",
          "section": "IFRS_2",
          "reference": "IFRS 2.52",
          "question": "If the entity has classified any share-based payment transactions as equity-settled under IFRS 2.33F, has it disclosed an estimate of the amount expected to be transferred to the tax authority to settle employees’ tax obligations, when necessary to inform users about future cash-flow effects?",
          "facet_focus": {
            "narrative_categories": [
              "disclosure_narrative"
            ],
            "table_archetypes": [],
            "quantitative_expectations": [
              "qualitative_only"
            ],
            "temporal_scope": [
              "current_period"
            ],
            "cross_reference_anchors": [
              "notes_main"
            ]
          },
          "conditionality": {
            "trigger_conditions": [
              "standard_requirement"
            ],
            "dependency_chain": [
              "identify_requirement"
            ],
            "exception_scenarios": [
              "not_applicable"
            ]
          },
          "evidence_expectations": {
            "required_documents": [
              "financial_statements"
            ],
            "data_sources": [
              "accounting_records"
            ],
            "validation_methods": [
              "document_review"
            ],
            "quality_indicators": [
              "completeness_check"
            ]
          },
          "retrieval_support": {
            "search_keywords": [],
            "section_indicators": [
              "notes"
            ],
            "pattern_matching": [
              "standard_format"
            ],
            "context_clues": [
              "financial_position"
            ]
          },
          "citation_controls": {
            "required_disclosures": [],
            "cross_references": [
              "related_standards"
            ],
            "compliance_markers": [
              "regulatory_compliance"
            ]
          }
        }
      ]
    }
  ]
}